Skip to main content
. 2023 Sep 27;23:e66.

TABLE 2.

OUTCOMES

Participant#/Defect# Morselizeda Graftb Number of product applications Time to 100% granulation tissue (days) %STSG take at 1 week Over time to heal (weeks) Complicate ns NPWT duration (weeks) Last long-term follow-up visit (weeks)
1 Yes 1 21 NA 6 Minor wound dehiscence 3 6
2A Yes Yes 1 21 100% 4 None 3 7
2B Yes 1 13 NA 6 None 3
3 Yes Yes 1 21 100% LTFU None 4 4
4 Yes 1 8 NA LTFU None 4 4
5 Yes Yes 1 43 NA LTFU None 4 8
6 Yes Yes 1 28 100% 6 None 4 8
7 Yes Yes 1 28 NA LTFU None 3 5
8A Yes 2 32 80% 7 None 4 8
8B Yes 2 32 75% 8 None 4
9A Yes 1 21 100% 4 None 3 5
9B Yes 1 21 100% 4 None 3
10 Yes Yes 1 15 NA 13 None 8 13
1.2 ± 0.4 (1.0)c 23.4 ± 9.2 (21.0)c 93.6 ±11.1% (100%)c 6.4 ± 2.8 (6.0)c 3.8 ± 1.3 (4.0)c 7.4 ± 2.4 (8.0)c
a

Myriad Morcells.

b

Myriad matrix.

c

Mean ± standard deviation; median is included in parentheses. LTFU. lost to follow-up before defect closure; NA, not available; NPWT, negative pressure wound therapy; STSG, split-thickness skin graft.